SEARCH

SEARCH BY CITATION

References

  • 1
    Chiaramonte M, Stroffolini T, Caporaso N, Coppola R, Craxì A, Gaeta GB, Sagnelli E, et al. Hepatitis C virus infection in Italy. Ital J Gastroenterol 1991; 23: 555558.
  • 2
    De Bac C, Stroffolini T, Gaeta GB, Taliani G, Giusti G. Pathogenic factors in cirrhosis with and without hepatocellular carcinoma: a multicenter Italian study. Hepatology 1994; 20: 14421449.
  • 3
    Simonetti RG, Cammà C, Fiorello F, Cottone M, Rapicetta M, Marino L, Fiorentino G, et al. Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case-control study. Ann Intern Med 1992; 116: 97102.
  • 4
    Stroffolini T, Chiaramonte M, Tiribelli C, Villa E, Simonetti R, Rapicetta M, Stazi MA, et al. Hepatitis C virus infection, HBsAg carrier state and hepatocellular carcinoma: Relative risk and population attributable risk from a case-control study in Italy. J Hepatol 1992; 16: 360363.
  • 5
    AlFaleh FZ, Ayoola EA, Aljeffry M, Alrashed R, Almofareh M, Arif M, Ramia S, et al. Prevalence of antibody to hepatitis C virus among Saudi Arabian children: a community based study. Hepatology 1991; 14: 215218.
  • 6
    Garcia-Fulgueiras A, Tormo MJ, Rodriguez T, Perez-Flores D, Chirlaque D, Navarro C. Prevalence of hepatitis B and C markers in the southeast of Spain: a community based serosurvey of 2,203 adults. Scand J Infect Dis 1996; 28: 1720.
  • 7
    Xia GL, Liu CB, Cao HL, Bi SL, Zhan MV, Su CA, Nan JH. Prevalence of hepatitis B and C virus infections in the general Chinese population. Results from a nationwide cross sectional seroepidemiologic study of hepatitis A,B,C,D, and E virus infections in China, 1992. Int Hepatol Commun 1993; 74: 23852390.
  • 8
    Tawaraya H, Ohkoshi S, Kuwana K, Watanabe M, Kamimura T, Asakura H. Epidemiologic survey and genetic analysis of endemic hepatitis C virus infection in a Japanese town with a high prevalence of hepatitis B virus carriers. J Med Virol 1995; 45: 367372.
  • 9
    Romanò L, Azara M, Chiaramonte M, De Mattia D, Giammanco A, Moschen ME, Scarpa B, et al. Low prevalence of anti-HCV antibody among Italian children. Infection 1994; 22: 350352.
  • 10
    D'Amelio R, Stroffolini T, Matricardi PM, Nisini R, Tosti ME, Trematerra M, Villano U, et al. Low prevalence of anti-HCV antibodies among Italian Air Force Recruits. Scand J Infect Dis 1995; 27: 1214.
  • 11
    Bellentani S, Pozzato G, Mazzoran L, Crocè LS, Santini F, Crovatto M, Barbisin M, et al. HCV genotype distribution in the general population of Northern Italy. J Hepatol 1996; 25 (S1): 145.
  • 12
    Stroffolini T, Menchinelli M, Taliani G, Dambruoso V, Poliandri G, Bozza A, Lecce R, et al. High prevalence of hepatitis C virus infection in a small central Italian town: lack of evidence of parenteral exposure. Ital J Gastroenterol 1995; 27: 235238.
  • 13
    Okamoto H, Sugiyama H, Okada S, Kurai K, Akahane Y, Sugai Y, Tanaka T, et al. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infection sources. J Gen Virol 1992; 73: 673679.
  • 14
    Simmonds P, Holmes EC, Cha TA, Chan SW, McOmish F, Irvine B, Beall E, et al. Classification of hepatitis C virus into six major genoptypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol 1993; 74: 23912399.
  • 15
    Dusheiko G, Schmilovitz-Weiss H, Brown D, McOmish F, Yap PL, Sherlock S, McIntyre N, et al. Hepatitis C virus genotypes: an investigation of type specific differences in geographic origin and disease. Hepatology 1994; 19: 1318.
  • 16
    Nousbaum JP, Pol S, Nalpas B, Landais P, Berthelot P, Brechot C. Hepatitis C virus type 1b infection in France and Italy. Ann Intern Med 1995; 122: 161168.
  • 17
    Rumi MG, Iacano OL, Mingall SA, Bernhardt XF, Chemello L, Civeira MP, Christofer F, et al. Epidemiological, clinical and therapeutic associations of hepatitis C types in Western European patients. J Hepatol 1996; 24: 517524.
  • 18
    Pontisso P, Ruvoletto MG, Nicoletti M, Tisminetzk YS, Gerotto M, Levrero M, Artini M, et al. Distribution of three major hepatitis C virus genotypes in Italy. A multicenter study of 495 patients with chronic heptaitis C. J Viral Hepat 1995; 2: 3338.
  • 19
    Silini E, Bono F, Cividini A, Cerino A, Bruno S, Rossi S, Belloni G. Differential distribution of hepatitis C virus genotypes in patients with and without liver function abnormalities. Hepatology 1995; 21: 285290.
  • 20
    McOmish F, Yap P, Dow BC, Follett EAC, Seed C, Keller A, Cobain TJ, et al. Geographical distribution of hepatitis C virus genotypes in blood donors: An international collaborative survey. J Clin Microbiol 1994; 32: 884892.
  • 21
    Shev S, Widell A, Foberg U, Fryden A, Hermodsson S, Lindh G, Lindholm A, et al. HCV genotypes in Swedish blood donors as correlated to epidemiology, liver disease and hepatitis C virus antibody profile. Infection 1995; 23: 253257.
  • 22
    Prati D, Capelli C, Zanella A, Mozzi F, Bosoni P, Pappalettera M, Zanuso F, et al. Influence of different hepatitis C virus genotypes on the course of asymptomatic hepatitis C virus infection. Gastroenterology 1996; 110: 178183.
  • 23
    Abramson JH. Survey methods in community medicine. New York, Churchill Livingstone, 1983: 2528.
  • 24
    Okamoto H, Tokita M, Sakamoto M, Horikita M, Lizuka H, Mishiro S. Characterization of the genomic sequence of type V (or 3a) hepatitis C virus isolates and PCR primers for specific detection. J Gen Virol 1993; 74: 23852390.
  • 25
    Spada E, Ciccaglione AR, Dettori S, Chionne P, Kondili L, Rapicetta M. HCV genotyping in the core region: an optimization of multiple PCR. IX Triennial International Symposium on Viral Hepatitis and Liver Disease 1996: 246 (Abstract C171).
  • 26
    Klinbaum DG, Kupper LL, Chambless LE. Logistic regression analysis of epidemiological data. Theory and practice. Commun Statist Theory Methods 1982; 71: 485547.
  • 27
    Kahn HA, Sempos CT. Statistical methods in epidemiology. New York, NY: Oxford University, 1989: 506558.
  • 28
    Chiaramonte M, Stroffolini T, Lorenzoni V, Minniti F, Conti S, Floreani, Ntakirutimana E, et al. Risk factors in community acquired hepatitis C virus chronic infection: A case control study in Italy. J Hepatol 1996; 24: 129134.
  • 29
    Silini E, Bono F, Cividini A, Cerino A, Maccabruni A, Tinelli C, Bruno S, et al. Molecular epidemiology of hepatitis C virus infection among intravenous drug users. J Hepatol 1995; 22: 691695.
  • 30
    Pawlotsky JM, Tsakiris L, Roudot-Thoraval F, Pellet C, Stuyver L, Duval J, Dhumeaux D. Relationship between hepatitis C virus genotypes and sources of infection in patients with chronic hepatitis C. J Infect Dis 1995; 11: 16071610.
  • 31
    Kaur S, Rybcki L, Bacon BR, Gollan JL, Rustgi VK, Carey WD. Performance characteristics and results of a large-scale screening program for viral hepatitis and risk factors associated with exposure to viral hepatitis B and C: Results of the National Hepatitis Screening Survey. Hepatology 1996; 24: 979986.
  • 32
    DiBisceglie AM, Goddman ZD, Ishak KG, Hoofnagle JH, Melpolder JJ, Alter HJ. Long-term clinical and histopathological follow-up of chronic post-transfusion hepatitis. Hepatology 1991; 14: 969974.
  • 33
    Tong MJ, El-Farra NS, Reikes AR, Co RL. Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 1995; 332: 14631466.
  • 34
    Alter MJ, Margolis HS, Krawczynski, Judson FN, Mares A, Alexander W J, Hu PA, et al. The natural history of community-acquired hepatitis C in the United States. N Engl J Med, 1992; 327: 18991905.
  • 35
    Seef LB, Buskell-Bales Z, Wright EC, Durako SJ, Alter HI, Iber FL, Hollinger FB, et al. Long-term mortality after transfusion-associated non-A, non-B hepatitis. N Engl J Med 1992; 327: 19061911.
  • 36
    Fattovich G, Giustina G, Degos F, Tremolada F, Diodati G, Almasio P, Nevens F, et al. Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterology 1997; 112: 463472.